Development and Validation of LC–MS/MS Method for Simultaneous Determination of Metformin and Four Gliptins in Human Plasma
- 20 March 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Chromatographia
- Vol. 80 (6), 891-899
- https://doi.org/10.1007/s10337-017-3288-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomesCardiovascular Diabetology, 2015
- Validation of RP-HPLC Method and Stress Degradation for the Combination of Metformin HCl, Atorvastatin Calcium and Glimepiride: Application to NanoparticlesJournal of Chromatographic Science, 2015
- Development and Validation of a Method for Simultaneous Estimation of Metformin and Sitagliptin in Human Plasma by LC–MS-MS and Its Application in a Bioequivalence StudyJournal of Chromatographic Science, 2015
- Simple HPLC-UV method for the quantification of metformin in human plasma with one step protein precipitationSaudi Pharmaceutical Journal, 2013
- A concise review of HPLC, LC‐MS and LC‐MS/MS methods for determination of azithromycin in various biological matricesBiomedical Chromatography, 2013
- Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trialsDiabetes, Obesity and Metabolism, 2011
- Fixed combination of repaglinide and metformin in the management of type 2 diabetesDiabetes, Metabolic Syndrome and Obesity, 2009
- Gliptins: a new class of oral hypoglycaemic agentQJM: An International Journal of Medicine, 2007
- Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese SubjectsThe Journal of Clinical Pharmacology, 2006
- Development and validation for high selective quantitative determination of metformin in human plasma by cation exchanging with normal-phase LC/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2005